English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Community

+ Community
Amanda Rupp | Aug 26, 2016

Scientists advance DNA research through extensive database

+ Regulatory
Amanda Rupp | Aug 26, 2016

AAFP handles difficult challenges in care management fees

+ Technology/Innovation
Amanda Rupp | Aug 26, 2016

Routine genital herpes screening found to be unsupported by evidence

+ Regulatory
Amanda Rupp | Aug 25, 2016

NORD broadens access to unapproved medicines

+ Technology/Innovation
Amanda Rupp | Aug 25, 2016

Anemic adults may have increased chances of death after stroke

+ Regulatory
Amanda Rupp | Aug 24, 2016

Evidence supports taxing sugary drinks for sake of heart health

+ Community
Amanda Rupp | Aug 24, 2016

Diabetes prevalence varies throughout U.S.

+ Technology/Innovation
Amanda Rupp | Aug 24, 2016

Lupus remains serious concern after long history of mortality

Trending

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation

  • « First
  • «
  • …
  • 436
  • 437
  • 438
  • 439
  • 440
  • 441
  • 442
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily